QS Investors’s MacroGenics MGNX Stock Holding History

QS Investors’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,100	Closed	-$227K	–	1180
2021 Q1	$227K	Buy	+7,100	New	+$172K	﹤0.01%	1073
2020 Q3	–	Sell	-39,400	Closed	-$1.1M	–	1394
2020 Q2	$1.1M	Buy	+39,400	New	+$684K	0.02%	696

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

QS Investors's MGNX Position: Q2 2021 in Review

QS Investors sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 7,100 shares — an estimated $227K sold.

QS Investors first reported a position in MGNX in Q2 2020 and held it in 2 quarters. The position peaked at $1.1M in Q2 2020. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

QS Investors reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
QS Investors sold 7,100 MacroGenics shares in Q2 2021, an estimated $227K.
QS Investors first reported a position in MacroGenics in Q2 2020 and held it in 2 quarters.
QS Investors's MacroGenics position peaked at $1.1M in Q2 2020.
149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.